GlassScriptPhysician profile
Joshua E Roller
NPI 1790713675
$248,196.30
in general payments reported to CMS, 2019-2025
30 companies · $75K in 2025
The $75K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $21K · 2021: $27K · 2022: $35K · 2023: $10K · 2024: $69K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Food and Beverage: $62K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $65,680.00 |
| Food and Beverage | $61,620.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,250.80 |
| Travel and Lodging | $363.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexington Medical, INC. | $124,316.38 | 2021-2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Medtronic, INC. | $79,974.89 | 2021-2025 | Ligasure, Signia, Endo Gia Ultra |
| Covidien LP | $31,380.56 | 2019-2020 | |
| Allergan, INC. | $4,978.89 | 2020-2023 | |
| Bolder Surgical, LLC | $3,000.00 | 2025 | Coolseal Generator |
| Abbvie INC. | $1,669.80 | 2023-2025 | |
| Baxter Healthcare | $1,041.74 | 2019-2024 | Adept, Recothrom, Seprafilm |
| Intuitive Surgical, INC. | $717.73 | 2019-2020 | |
| Hologic Sales and Service, LLC | $277.97 | 2024-2025 | Coolseal Generator |
| Stryker Corporation | $206.02 | 2022 | |
| Endo Pharmaceuticals INC. | $78.96 | 2020-2021 | |
| Endolumik, INC. | $75.94 | 2025 | Endolumik Gastric Calibration Tube |
| Novo Nordisk INC | $59.93 | 2019-2021 | |
| Tela Bio, INC. | $56.98 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $38.78 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $33.91 | 2024 | Voquezna |
| Olympus America INC. | $32.72 | 2023-2024 | Olympus, Olympus |
| W. L. Gore & Associates, INC. | $32.04 | 2021 | |
| Steris Corporation | $27.06 | 2025 | |
| Redhill Biopharma INC. | $26.90 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $26.58 | 2024 | Exparel, Iovera |
| Midsouth Orthopedics INC. | $22.18 | 2020 | |
| Conmed Corporation | $19.19 | 2024 | Airseal |
| Davol INC. | $18.94 | 2021 | |
| Teleflex LLC | $17.54 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.00 | 2021 | |
| Boston Scientific Corporation | $16.17 | 2019 | |
| Revance Therapeutics, INC. | $15.06 | 2025 | Daxxify |
| Apyx Medical Corporation | $12.07 | 2019 | |
| Bolder Surgical LLC | $4.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Roller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.